Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1974 May;33(3):268–272. doi: 10.1136/ard.33.3.268

Studies on 4-allyloxy-3 chlorophenylacetic acid (Alcofenac). A double-blind comparison of Alcofenac and aspirin in rheumatoid arthritis, and effects of therapy on serum immunoglobulins and rheumatoid factor.

M Aylward, R J Parker, J Maddock
PMCID: PMC1006254  PMID: 4602026

Full text

PDF
269

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anylward M., Davies D. B. A double-blind crossover trial comparing a new antirheumatic agent alclofenac with phenylbutazone in chronic rheumatic disorders. Br J Clin Pract. 1972 Nov;26(11):517–523. [PubMed] [Google Scholar]
  2. Aylward M. Alclofenac in rheumatoid arthritis: an evaluation of its anti-inflammatory and analgesic effects. Br J Clin Pract. 1973 Jul;27(7):255–260. [PubMed] [Google Scholar]
  3. Bluestone R., Goldberg L. S. Effect of D-penicillamine on serum immunoglobulins and rheumatoid factor. Ann Rheum Dis. 1973 Jan;32(1):50–52. doi: 10.1136/ard.32.1.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boardman P. L., Hart F. D. Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis. Br Med J. 1967 Nov 4;4(5574):264–268. doi: 10.1136/bmj.4.5574.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Buu-Hoï N. P., Lambelin G., Gillet C., Roba J., Staquet M. 4-Allyloxy-3-chlorophenylacetic acid, a new type of analgesic, antipyretic and antiphlogistic drug. Naturwissenschaften. 1969 Jun;56(6):330–331. doi: 10.1007/BF00602182. [DOI] [PubMed] [Google Scholar]
  6. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis. 1959 Mar;18(1):49–53. [PMC free article] [PubMed] [Google Scholar]
  7. Lambelin G., Roba J., Gillet C., Buu-Hoï N. P. Pharmacology of a new analgesic, antipyretic, and anti-inflammatory agent, 4-allyloxy-3-chlorophenylacetic acid. Arzneimittelforschung. 1970 May;20(5):610–618. [PubMed] [Google Scholar]
  8. Lambelin G., Roba J., Gillet C., Gautier M., Buu-Hoï N. P. Toxicity studies of 4-allyloxy-3-chlorophenylacetic acid, a new analgesic, antipyretic, and anti-inflammatory agent. Arzneimittelforschung. 1970 May;20(5):618–630. [PubMed] [Google Scholar]
  9. Ory M. Etude clinique de l'alclofénac oral et parentérall dans des affections rhumatismales aiguës. Brux Med. 1971 Sep;51(9):615–619. [PubMed] [Google Scholar]
  10. Pavelka K., Vojtísek O., Brémova A., Kanková D., Handlová D. Double-blind comparison of alclofenac and phenylbutazone in the short-term treatment of rheumatoid arthritis. Curr Med Res Opin. 1973;1(6):342–350. doi: 10.1185/03007997309111691. [DOI] [PubMed] [Google Scholar]
  11. Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES